| Current Price | $93.80 | Mkt Cap | $5.3B |
|---|---|---|---|
| Open | $96.10 | P/E Ratio | 0.00 |
| Prev. Close | $95.82 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $93.18 - $96.63 | Volume | 836,440 |
| 52-Wk Range | $84.26 - $99.36 | Avg. Daily Vol. | 1,373,212 |
| Current Price | $93.80 | Mkt Cap | $5.3B |
|---|---|---|---|
| Open | $96.10 | P/E Ratio | 0.00 |
| Prev. Close | $95.82 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $93.18 - $96.63 | Volume | 836,440 |
| 52-Wk Range | $84.26 - $99.36 | Avg. Daily Vol. | 1,373,212 |
The best Bull and Bear pitches based on recency and number of recommendations.
I am very impressed with Nick Leschly. You can watch his Ted Talk here:https://www.youtube.com/watch?v=Ez560GnkSrE
Selling for a while after the huge drop today, good for a trade
Read the most recent pitches from players about BLUE.
Recs
wrciii
(50.27)
Submitted: 1/3/2020 7:32:05 PM :
Start Price:
$87.16
NASDAQ:BLUE Score:
+4.39
David Nie Wedbush
Recs
SurfingCabarete
(38.36)
Submitted: 7/9/2019 12:18:18 PM :
Start Price:
$131.71
NASDAQ:BLUE Score:
-40.46
another bet on gene editing
Recs
jbonefish
(54.28)
Submitted: 6/14/2019 10:51:02 PM :
Start Price:
$118.05
NASDAQ:BLUE Score:
-35.01
In the “age of miracles” Bluebird is out in front in applying the science and focused on the types of diseases (single gene mutations) that are most likely to result in breakthrough treatments initially. Rather than being a good moonshot story, BLUE is doing the work that will solve problems for patients - that is a better recipe for long term financial success than a good story.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (34.47) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| portefeuille12 | 29.02 | 4/16/2014 |
|
5Y | $19.11 | +390.84% | +78.47% | +312.37 | 0 Comment | |
| portefeuille2 | 99.17 |
|
|
5Y | $20.74 | +352.27% | +82.20% | +270.07 | 0 Comment | |
| portefeuille3 | 97.27 | 4/11/2014 |
|
5Y | $20.74 | +352.27% | +82.35% | +269.92 | 0 Comment | |
|
efarev | 98.51 | 11/5/2013 |
|
5Y | $20.53 | +356.89% | +88.28% | +268.61 | 0 Comment |
| johninmadison | 82.63 | 4/7/2014 |
|
5Y | $21.07 | +345.18% | +78.28% | +266.90 | 0 Comment | |
| portefeuille6 | 99.38 | 4/11/2014 |
|
5Y | $20.91 | +348.59% | +82.59% | +266.00 | 0 Comment | |
| HoosierDoozer | < 20 | 2/5/2014 |
|
5Y | $20.84 | +350.10% | +89.61% | +260.49 | 0 Comment | |
| portefeuille | 98.46 | 4/8/2014 |
|
5Y | $21.44 | +337.50% | +79.79% | +257.71 | 1 Comment | |
| jack0071 | 72.54 | 1/8/2014 |
|
5Y | $21.47 | +336.89% | +80.66% | +256.23 | 0 Comment | |
| jtothes | 71.32 | 2/14/2014 |
|
3Y | $21.88 | +328.70% | +81.26% | +247.44 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
